Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arimidex and Zoladex as pretreatment to IVF in ovarian endometriosis
NCT00286351Phase 4Completed
- Sponsor
- Rigshospitalet
- Start
- Jan 2005
- Modality
- Irreversible Covalent Inhibitors, Orthosteric Ligands, Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of anastrozole, goserelin in endometriosis, sponsored by Rigshospitalet. Started Jan 2005; status: completed.
02
Drugs
anastrozolegoserelin
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT00286351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00286351.